SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-080642
Filing Date
2020-03-20
Accepted
2020-03-20 16:06:56
Documents
3
Period of Report
2020-03-20
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d907643d8k.htm 8-K 19625
2 EX-16.1 d907643dex161.htm EX-16.1 3410
3 GRAPHIC g907643g95g59.jpg GRAPHIC 3761
  Complete submission text file 0001193125-20-080642.txt   29699
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 20732051
SIC: 2834 Pharmaceutical Preparations